Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
  89R16099 SCR-D     By: Bell of Montgomery H.B. No. 4756       A BILL TO BE ENTITLED   AN ACT   relating to certain advertisements for prescription drugs.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Subtitle A, Title 16, Business & Commerce Code,   is amended by adding Chapter 722 to read as follows:   CHAPTER 722.   CERTAIN ADVERTISEMENTS FOR PRESCRIPTION DRUGS           Sec.   722.001.     DEFINITION. In this chapter, "paid   advertisement" means a communication that promotes a good or   service and is disseminated in exchange for consideration.           Sec.   722.002.     PROHIBITED ADVERTISEMENT OF CERTAIN   PRESCRIPTION DRUGS.   (a)   A person may not disseminate a paid   advertisement for a prescription drug.           (b)     Subsection (a) does not apply to a paid advertisement   disseminated:                 (1)     only to medical, dental, or nursing professionals   in a professional scientific periodical; or                 (2)     only for public health education by a person who is   not directly or indirectly commercially interested in the sale of   the drug.           Sec.   722.003.     DECEPTIVE TRADE PRACTICE. A violation of   Section 722.002 is a deceptive trade practice in addition to the   practices described by Subchapter E, Chapter 17, and is actionable   under that subchapter.          SECTION 2.  This Act takes effect September 1, 2025.